Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

NCT05089227 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Prolonged Anticoagulation
Venous Thromboembolic Disease
Autoimmune Hemolytic Anemia

Interventions

DRUG: treatment "intervention"
DRUG: treatment "standard"
BIOLOGICAL: biological assessment

Sponsor

Centre Hospitalier Universitaire Dijon